Skip to content

Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy

Perfusion Mapping and Tissue Characterization Using Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07803315
Acronym
HSI-Renal
Enrollment
60
Registered
2026-09-03
Start date
2026-09-01
Completion date
2028-08-01
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Neoplasm, Renal Mass up to 7cm

Keywords

Kidney Tumor, Partial Nephrectomy, Robotic Surgical Procedures, Minimally Invasive Surgical Procedures, Optical Imaging

Brief summary

The goal of this prospective observational study is to learn about the use of a novel imaging technique called hyperspectral imaging in adult participants who are having surgery for removing a tumor from their kidney. Hyperspectral imaging works by shining light on a structure (in this case, the kidney tissue with the tumor) and capturing how it reflects hundreds of very narrow color bands, including ones the human eye can't see. These patterns depend on the composition of the tissue and for example how well blood is flowing through the tissue. By studying these patterns, the investigators want to understand if this technique can be helpful for the surgery where only the part of the kidney with the tumor is removed. The main questions it aims to answer are: * Can hyperspectral imaging show the areas of blood flow in the kidney during surgery? * Is there a connection between the detected patterns of light and the type of kidney tumor? The imaging will happen during the already planned surgery and the participant does not need to undergo any additional tests.

Interventions

None listed

Sponsors

University of Leipzig
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a kidney tumor ≤7cm * planned robot-assisted partial nephrectomy * age ≥ 18 years

Exclusion criteria

* patients with a previous surgery on the affected kidney * patients with a fully intrarenal/endophytic tumor without an exophytic component * previous malignancy with ongoing or planned nephrotoxic chemotherapy * current immunosuppression (e.g., organ transplantation, leukemia) * pregnancy, lactation, or women who wish to have children * inability to give informed consent

Design outcomes

Primary

MeasureTime frame
Correlation of hyperspectral imaging (HSI) data with clamping technique during robot-assisted partial nephrectomy (RAPN)day of surgery
Correlation of HSI data with histopathological reportday of surgery

Secondary

MeasureTime frame
Correlation of HSI data with demographic parametersday of surgery
Correlation of HSI data and respective clamping technique with postoperative kidney functionfrom the day of surgery until discharge (up to 6 days)

Countries

Germany

Contacts

CONTACTJens-Uwe Stolzenburg, Professor Dr.
jens-uwe.stolzenburg@medizin.uni-leipzig.de+49 3419717600
CONTACTDoreen Trebst, Dr.
doreen.trebst@medizin.uni-leipzig.de+49 3419717610

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026